Chemoinformaics analysis of Decaffeoylverbascoside
| Molecular Weight | 462.448 | nRot | 7 |
| Heavy Atom Molecular Weight | 432.208 | nRig | 18 |
| Exact Molecular Weight | 462.174 | nRing | 3 |
| Solubility: LogS | -0.796 | nHRing | 2 |
| Solubility: LogP | -2.151 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 1 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 6 |
| nHA | 12 | APOL | 63.0278 |
| nHD | 8 | BPOL | 37.0402 |
| QED | 0.196 |
| Synth | 4.387 |
| Natural Product Likeliness | 2.135 |
| NR-PPAR-gamma | 0.112 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.672 |
| HIA | 0.99 |
| CACO-2 | -6.297 |
| MDCK | 0.000216463 |
| BBB | 0.478 |
| PPB | 0.267833 |
| VDSS | 0.298 |
| FU | 0.646401 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.031 |
| CYP2c19-inh | 0.012 |
| CYP2c19-sub | 0.095 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.56 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.165 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.008 |
| CL | 1.34 |
| T12 | 0.62 |
| hERG | 0.014 |
| Ames | 0.262 |
| ROA | 0.092 |
| SkinSen | 0.047 |
| Carcinogencity | 0.063 |
| EI | 0.007 |
| Respiratory | 0.018 |
| NR-Aromatase | 0.17 |
| Antiviral | Yes |
| Prediction | 0.708671 |